Spots Global Cancer Trial Database for hodgkin disease recurrent
Every month we try and update this database with for hodgkin disease recurrent cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy | NCT05352828 | Classical Hodgk... Hodgkin Disease... Hodgkin Disease... | Nivolumab Autologous CD30... Fludarabine Bendamustine | 12 Years - | Tessa Therapeutics | |
Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy | NCT05352828 | Classical Hodgk... Hodgkin Disease... Hodgkin Disease... | Nivolumab Autologous CD30... Fludarabine Bendamustine | 12 Years - | Tessa Therapeutics |